CIK 0001750284
- Non-accelerated filer
- Smaller reporting company
Olema Oncology, Inc.
Sign in to watch- Ticker
- OLMA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 300409740
- Phone
- +1 415-651-3316
- Business address
- 365 OYSTER POINT BOULEVARD, SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Olema Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-19 | Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | Sale | −43,729 | $30.40 | $1.3M | 557,927 |
| 2025-12-19 | Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | Sale | −6,046 | $31.39 | $190K | 551,881 |
| 2025-12-19 | CLARK IAN T Director | Sale | −29,904 | $28.83 | $862K | 234,896 |
| 2025-12-19 | CLARK IAN T Director | Sale | −193,056 | $29.71 | $5.7M | 41,840 |
| 2025-12-19 | CLARK IAN T Director | Sale | −41,840 | $30.48 | $1.3M | 0 |
| 2025-09-18 | Harmon Cyrus Director | Sale | −10,000 | $8.33 | $83K | 744,140 |
| 2025-09-18 | Harmon Cyrus Director | Sale | −3,086 | $8.32 | $26K | 117,028 |
| 2025-09-16 | Harmon Cyrus Director | Sale | −10,000 | $8.04 | $80K | 754,140 |
| 2025-09-16 | Harmon Cyrus Director | Sale | −1,914 | $8.08 | $15K | 120,114 |
| 2024-12-17 | Graham G. Walmsley Director | Sale | −700,761 | $6.75 | $4.7M | 0 |
| 2024-12-13 | Graham G. Walmsley Director | Sale | −700,761 | $6.75 | $4.7M | 0 |
| 2024-12-11 | Harmon Cyrus Director | Sale | −7,958 | $8.66 | $69K | 764,319 |
| 2024-12-11 | Harmon Cyrus Director | Sale | −179 | $9.39 | $2K | 764,140 |
| 2024-12-11 | Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | Sale | −13,314 | $8.66 | $115K | 598,633 |
| 2024-12-11 | Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | Sale | −300 | $9.39 | $3K | 598,333 |
| 2024-12-11 | Zojwalla Naseem CHIEF MEDICAL OFFICER | Sale | −14,202 | $8.66 | $123K | 115,829 |
| 2024-12-11 | Zojwalla Naseem CHIEF MEDICAL OFFICER | Sale | −320 | $9.39 | $3K | 115,509 |
| 2024-12-11 | Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF. | Sale | −17,950 | $8.66 | $155K | 543,955 |
| 2024-12-11 | Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF. | Sale | −406 | $9.39 | $4K | 543,549 |
| 2024-12-11 | Bohen Sean PRESIDENT AND CEO | Sale | −55,907 | $8.66 | $484K | 242,929 |
Page 2 of 7 · 131 trades